ILiAD Biotechnologies (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- September 06, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $42,800,000
Company Info
- Founders
- Keith Rubin, MD
- Company Description
- ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
- Market
- Human disease prevention and treatment
- Location
- Weston, FL, USA
- Coinvestors
- Knott Partners